These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 16160080)
21. Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf. Wagner S; Roemer K Biochem Pharmacol; 2005 Apr; 69(7):1059-67. PubMed ID: 15763542 [TBL] [Abstract][Full Text] [Related]
22. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene]. Shen WJ; Dai DQ; Teng Y; Liu J Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115 [TBL] [Abstract][Full Text] [Related]
23. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. Chen Z; Clark S; Birkeland M; Sung CM; Lago A; Liu R; Kirkpatrick R; Johanson K; Winkler JD; Hu E Cancer Lett; 2002 Dec; 188(1-2):127-40. PubMed ID: 12406558 [TBL] [Abstract][Full Text] [Related]
24. A bipartite butyrate-responsive element in the human calretinin (CALB2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells. Häner K; Henzi T; Pfefferli M; Künzli E; Salicio V; Schwaller B J Cell Biochem; 2010 Feb; 109(3):519-31. PubMed ID: 19998412 [TBL] [Abstract][Full Text] [Related]
25. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol. Rosato RR; Almenara JA; Yu C; Grant S Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235 [TBL] [Abstract][Full Text] [Related]
26. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Kim JS; Cross JM; Bamman MM Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1110-9. PubMed ID: 15644458 [TBL] [Abstract][Full Text] [Related]
27. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445 [TBL] [Abstract][Full Text] [Related]
28. Physalis angulata induced G2/M phase arrest in human breast cancer cells. Hsieh WT; Huang KY; Lin HY; Chung JG Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178 [TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Blottière HM; Buecher B; Galmiche JP; Cherbut C Proc Nutr Soc; 2003 Feb; 62(1):101-6. PubMed ID: 12740064 [TBL] [Abstract][Full Text] [Related]
30. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
31. Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. Iacomino G; Tecce MF; Grimaldi C; Tosto M; Russo GL Biochem Biophys Res Commun; 2001 Aug; 285(5):1280-9. PubMed ID: 11478796 [TBL] [Abstract][Full Text] [Related]
32. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680 [TBL] [Abstract][Full Text] [Related]
33. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells]. Lv BH; Zhang L; Zhu CC; Liu J Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303 [TBL] [Abstract][Full Text] [Related]
34. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. Koyama N; Koschmieder S; Tyagi S; Nürnberger H; Wagner S; Böcker U; Hoelzer D; Gerhard Ottmann O; Kalina U Biochem Biophys Res Commun; 2002 Apr; 292(4):937-43. PubMed ID: 11944905 [TBL] [Abstract][Full Text] [Related]
36. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Mariadason JM; Corner GA; Augenlicht LH Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808 [TBL] [Abstract][Full Text] [Related]
37. Repression of HIP/RPL29 expression induces differentiation in colon cancer cells. Liu JJ; Huang BH; Zhang J; Carson DD; Hooi SC J Cell Physiol; 2006 May; 207(2):287-92. PubMed ID: 16475173 [TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells. Dagtas AS; Edens RE; Gilbert KM Int Immunopharmacol; 2009 Oct; 9(11):1289-97. PubMed ID: 19664724 [TBL] [Abstract][Full Text] [Related]
39. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors. Ellis DJ; Lawman ZK; Bonham K Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771 [TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post-transcriptional level in HepG2 cells. Hirsch CL; Bonham K FEBS Lett; 2004 Jul; 570(1-3):37-40. PubMed ID: 15251435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]